Authors: Mary A. Williamson Mt(ascp) Phd,L. Michael Snyder Md
Cutoff concentration: 10 ng/mL
No cross-reactivity with clonazepam, flunitrazepam, lorazepam and metabolites, and oxazepam
EMIT (serum/urine)
Target analyte: nitrazepam (urine), diazepam (serum)
Cutoff concentration: 200 or 300 ng/mL urine, 50 ng/mL serum
Due to low cross-reactivity, will
not
detect flunitrazepam, clonazepam, lorazepam (urine); low cross-reactivity with chlordiazepoxide and demoxepam (serum)
Cross-reactivity with alprazolam manufacturer (vendor) dependent
Confirmation for urine and serum
Sample pretreatment necessary
Derivatization may be necessary for metabolite detection.
Hydrolysis of urine samples increases detectability.
Gas chromatography (GC).
HPLC.